Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Guardant Health, Bristol-Myers Squibb to Deploy Liquid Biopsies in Clinical Trials

Guardant Health, Bristol-Myers Squibb to Deploy Liquid Biopsies in Clinical Trials

Nov 16, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Guardant Health said today that it is working with Bristol-Myers Squibb to develop the GuardantOMNI assay, a 500-plus-gene liquid biopsy panel designed to accelerate clinical trials and targeted cancer therapy research.

Redwood City, California-based Guardant has struck similar partnerships with AstraZeneca, Merck, Merck KGaA, and Pfizer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Genomics to Trace, Prevent

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Sense of Scope in San Diego

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Boost to Wolf Diversity

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

Science Papers Present Algorithm to Diagnose Slowly Progressing Diseases, Korean Genome Project

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.

Jun
02
Featured Webinar

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

Sponsored by
NanoString

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
09
Featured Webinar

Our Magic DRAGEN: A Sequencing Lab Case Study on Accelerated Bioinformatics

Sponsored by
Illumina

In this webinar, Dr. Charlie Johnson, founder of the Texas A&M AgriLife Genomics and Bioinformatics Service, will share how his team is utilizing Illumina’s DRAGEN informatics platform in its high-throughput agrigenomics research program. 

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Sequencing

  1. Metatranscriptomic Study of COVID-19 Patients Shows More Disrupted Airway Microbiome

  2. Ginkgo Bioworks Nabs $70M Investment from Illumina, Others to Build Coronavirus NGS Testing

  3. Progenity Files for IPO, Seeks to Raise up to $100M

  4. Tumor Microbiome Appears to Vary With Cancer Type

  5. Ancient DNA Analysis Describes Farmer, Hunter-Gatherer Interactions In Neolithic Europe

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.